-
EP0749752
European procedure
Extract from the Register of European Patents
EP About this file: EP0749752
| EP0749752 - Use of specific RXR receptor ligands [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.03.2003 Database last updated on 22.01.2025 | Most recent event Tooltip | 17.04.2015 | Change - lapse in a contracting state | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) 635, route des Lucioles, Sophia Antipolis 06560 Valbonne / FR | [2002/19] |
| Former [1996/52] | For all designated states CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) 635, route des Lucioles, Sophia Antipolis F-06560 Valbonne / FR | Inventor(s) | 01 /
Demarchez, Michel 154, route de Saint Michel 06620 Le Bar sur Loup / FR | 02 /
Jomard, André 20 bis, avenue François Goby 06460 Saint Vallier de Thiey / FR | [1996/52] | Representative(s) | Andral, Christophe André Louis L'Oréal Service DIPI 9 Rue Pierre Dreyfus 92110 Clichy / FR | [N/P] |
| Former [1996/52] | Andral, Christophe André Louis L'OREAL Centre de Recherche Charles Zviak Département Propriété Industrielle 90, rue du Général Roguet 92583 Clichy Cedex / FR | Application number, filing date | 96401140.7 | 28.05.1996 | [1996/52] | Priority number, date | FR19950007300 | 19.06.1995 Original published format: FR 9507300 | [1996/52] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | EP0749752 | Date: | 27.12.1996 | Language: | FR | [1996/52] | Type: | B1 Patent specification | No.: | EP0749752 | Date: | 08.05.2002 | Language: | FR | [2002/19] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.09.1996 | Classification | IPC: | A61K31/59, A61K31/20, A61K31/19, A61P17/00 | [2002/02] | CPC: |
A61K31/593 (EP,US);
A61K31/192 (EP,US);
A61K31/203 (EP,US);
A61K31/592 (EP,US);
A61P17/00 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/08 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP)
(-)
|
| Former IPC [1996/52] | A61K31/59, A61K31/20, A61K31/19 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/52] | Title | German: | Verwendung von spezifischen RXR-Rezeptorliganden | [2002/02] | English: | Use of specific RXR receptor ligands | [1996/52] | French: | Utilisation de ligands spécifiques des récepteurs RXRs | [1996/52] |
| Former [1996/52] | Verwendung von spezifische RXR-Rezeptorligande | Examination procedure | 25.11.1996 | Examination requested [1997/05] | 25.11.1996 | Request for accelerated examination filed | 24.09.1999 | Despatch of a communication from the examining division (Time limit: M04) | 24.09.1999 | Decision about request for accelerated examination - accepted: Yes | 14.01.2000 | Reply to a communication from the examining division | 25.02.2000 | Despatch of a communication from the examining division (Time limit: M04) | 09.06.2000 | Reply to a communication from the examining division | 30.11.2000 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2001 | Reply to a communication from the examining division | 02.07.2001 | Despatch of a communication from the examining division (Time limit: M03) | 13.09.2001 | Reply to a communication from the examining division | 14.01.2002 | Despatch of communication of intention to grant (Approval: Yes) | 25.02.2002 | Fee for grant paid | 25.02.2002 | Fee for publishing/printing paid | 08.03.2002 | Communication of intention to grant the patent | Opposition(s) | 11.02.2003 | No opposition filed within time limit [2003/18] | Fees paid | Renewal fee | 02.06.1998 | Renewal fee patent year 03 | 12.05.1999 | Renewal fee patent year 04 | 15.05.2000 | Renewal fee patent year 05 | 14.05.2001 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2007/16] | LU | 08.07.2002 | Documents cited: | Search | [A]WO9415901 (LIGAND PHARM INC [US]); | [A]WO9417796 (ALLERGAN INC [US]); | [E] - B. ROY ET AL., "Synergistic activation of retinoic acid-responsive genes and induction of ebryonal carcinoma cell differentiation by an RA receptor alpha , RARbeta or RARgamma-selective ligand in combination with a retinoid X receptor-specific ligand.", MOL. CELL. BIOL., (1995), vol. 15, no. 12, pages 6481 - 6487, XP000565384 [E] 1-12 * the whole document * | [A] - E.D. ROSEN ET AL., "Ligand-dependent synergy of thyroid hormone and retinoid receptors.", J.BIOL. CHEM., (1992), vol. 267, no. 31, pages 22010 - 22013, XP000565364 |